-
Markets
-
Equities
Sustainable finance2025 Euronext ESG Trends ReportRead moreA data-driven snapshot of how Euronext-listed companies are advancing their Environmental, Social and Governance (ESG) practices.
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesRead moreThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
ETFs
The European market place for ETFsEuronext ETF EuropeRead moreInvestors benefit from a centralised market place that will not only bring transparency but also better pricing due to the grouping of liquidity.
- Funds
-
Fixed Income
European Defence BondsGroupe BPCE lists the first bondRead moreFirst financial institution in Europe to issue a bond dedicated to the defence sector
- Structured Products
-
Derivatives
Where European Government Bonds Meet the FutureFixed Income derivativesRead moreTrade mini bond futures on main European government bonds
-
Commodities
- Overview
- Quotes snapshot
- Power Derivatives
- Milling Wheat derivatives
- Corn derivatives
- Spread contracts
- Rapeseed derivatives
- Durum Wheat derivatives
- Salmon derivatives
- Delivery & settlement
- Specifications & arrangements
- Commitments of Traders (CoT) report
- Commodity brokers
Building a sustainable and liquid power derivatives market.Euronext Nord Pool Power FuturesRead moreEuronext and Nord Pool, the European power exchange, announced the launch of a dedicated Nordic and Baltic power futures market.
-
Resources
Designed to help students navigate the complexities of financial marketsEuronext Trading gameRead moreJoin the Euronext Trading Game and step into capital markets. Learn from today’s leaders, explore sustainable opportunities, and trade with confidence.
Neurones: 6.3% net profit in 1st half 2025
10 Sep 2025 17:40 CEST
Issuer
NEURONES
PRESS INFORMATION
Heading: 1st half 2025 results Nanterre, September 10, 2025 (after trading)
6.3% net profit in 1st half 2025
| (in millions of euros) | H1 2024 | 2024 | H1 2025 * |
| Revenues | 402.4 | 810.4 | 424.3 |
| Business operating profit ** | 40.5 (10.1%) | 84.1 (10.4%) | 37.4 (8.8%) |
| Operating profit | 37.1 (9.2%) | 77.9 (9.6%) | 33.1 (7.8%) |
| Net financial profit | 4.7 | 10.2 | 4.8 |
| Income tax | (12.6) | (24.9) | (11.1) |
| Net profit after tax | 29.2 (7.3%) | 63.2 (7.8%) | 26.8 (6.3%) |
| of which, group share | 24.5 | 52.5 | 22.7 |
| Net cash excluding financial debt *** | 256.9 | 319.5 | 282.2 |
| Staff at end of period (ppl) | 7,001 | 7,087 | 7,264 |
* Financial statements as of June 30, 2025, approved by the Board of Directors on September 10.
** Before cost of bonus shares.
*** Excluding IFRS16 lease liabilities.
Achievements
As previously announced, the Group posted growth of 5.4% in the first half of the year (including 4.6% with constant structures), despite an unfavorable economic environment.
At the end of the first half-year:
- operating profit was confirmed at 7.8% after new social security and tax charges (approximately 0.4% of revenues). It mainly reflects pressure on gross margins (price pressure, slight increase in inter-contract periods, etc.);
- net profit, group share, amounted to 5.3% of revenues;
- net cash (excluding IFRS 16 lease liabilities) increased by €25.3 million compared to June 30, 2024.
Outlook
In a persistently uncertain climate, NEURONES confirms its latest forecasts for the full year:
- revenues of nearly €850 million,
- operating profit of approximately 8%.
About NEURONES
With over 7,250 experts, and ranking among the French leaders in management consulting and digital services, NEURONES helps large companies and organizations implement their digital projects, transform their IT infrastructures and adopt new uses.
Euronext Paris (compartment A - NRO) – Euronext Tech Leaders – DSS – PEA-PME eligible
www.neurones.net
| Press Relations: O'Connection Julia Philippe-Brutin Tel.: +33 (0)6 03 63 06 03 jpbrutin@oconnection.fr | NEURONES Matthieu Vautier Tel.: +33 (0)1 41 37 41 37 rp@neurones.net | Investor Relations: NEURONES Paul-César Bonnel Tel.: +33 (0)1 41 37 41 37 investisseurs@neurones.net |
Attachment
Source
NEURONES
Provider
GlobeNewswire
Company Name
NEURONES
ISIN
FR0004050250
Symbol
NRO
Market
Euronext